NASDAQ NMS - GLOBAL MARKET · GCTK
-4.96% · -$0.0600 · Vol 176.3K
Live · updated 11:58:30 ET
GlucoTrack Inc

GlucoTrack Inc

Health Care
$1.09
Card
Relationship Map

Follow $GCTK

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $GCTK by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
GCTK
GlucoTrack Inc
Wed Oct 7 · last completed session · daily score · 17h old
Lowest range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

23/ 100
Veridion Score
Lowest range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4 of 6 factors measured · Wed Oct 7 · last completed session · daily score · 17h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is GCTK moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading GCTK catalysts
About GlucoTrack Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2000
Employees
15
Country
US

GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.12
Day high
$1.21
Day low
$1.09
Previous close
$1.15
52W high
$128.40
-99.15% from high
52W low
$1.09
0% of range
Market cap
$1.2M
EPS
$-115.3552
Beta
3.63
Shares out
1M
Volume
176.3K
0.06× rel vol
Avg volume
2.9M
VWAP
$1.13
Price history computed in-house
1W
-22.48%
1M
-62.70%
3M
-82.54%
1Y
-99.15%
YTD
-98.12%
SMA 50 $4.02 · below
SMA 200 $16.71 · below
52W position 0%

GCTK overview

Veridion Score
23
Registered · 2026-10-07
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around GCTK.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading GCTK Form 4 filings
Public disclosures

Congress activity in GCTK

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

GCTK contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GCTK in this window.
Lobbying spend

GCTK lobbying filings, year to date.

Registered lobbying filings matched to GlucoTrack Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GCTK in this window.
Loading news for GCTK
Analyst ratings
Sovereign unlock shows live analyst consensus for GCTK.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.